IL1B and metastatic prostate carcinoma: In summary, tumor cells produce and secrete IL-1β either in conjunction with or as an alternative to immune cells, contributing to an inflammatory microenvironment but also altering the gene expression profiles of tumor-associated stromal cells, as reported in pre-clinical models of metastatic prostate cancer [63].